PURPLE BIOTECH LTD-ADR (PPBT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PPBT - US74638P1093 - ADR

0.64 USD

0 (0%)

Last: 1/29/2026, 11:12:55 AM

Fundamental Rating

Taking everything into account, PPBT scores 1 out of 10 in our fundamental rating. PPBT was compared to 190 industry peers in the Pharmaceuticals industry. PPBT has a bad profitability rating. Also its financial health evaluation is rather negative. PPBT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

PPBT had negative earnings in the past year.
In the past year PPBT has reported a negative cash flow from operations.
In the past 5 years PPBT always reported negative net income.
In the past 5 years PPBT always reported negative operating cash flow.

1.2 Ratios

PPBT has a better Return On Assets (-8.32%) than 68.95% of its industry peers.
PPBT's Return On Equity of -9.92% is fine compared to the rest of the industry. PPBT outperforms 74.21% of its industry peers.

		Industry Rank	Sector Rank
ROA	-8.32%
ROE	-9.92%
ROIC	N/A

ROA(3y)-34.7%

ROA(5y)-32.74%

ROE(3y)-42.11%

ROE(5y)-37.99%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PPBT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for PPBT has been increased compared to 1 year ago.
PPBT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PPBT has been reduced compared to a year ago.

2.2 Solvency

PPBT has an Altman-Z score of -4.00. This is a bad value and indicates that PPBT is not financially healthy and even has some risk of bankruptcy.
PPBT's Altman-Z score of -4.00 is on the low side compared to the rest of the industry. PPBT is outperformed by 61.05% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PPBT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, PPBT is doing good in the industry, outperforming 61.05% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-4

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 1.78 indicates that PPBT should not have too much problems paying its short term obligations.
PPBT's Current ratio of 1.78 is on the low side compared to the rest of the industry. PPBT is outperformed by 66.32% of its industry peers.
PPBT has a Quick Ratio of 1.78. This is a normal value and indicates that PPBT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.78, PPBT perfoms like the industry average, outperforming 42.63% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	1.78

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.67% over the past year.

EPS 1Y (TTM)85.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.